Last reviewed · How we verify

NCT03429634

Balloon-Stent Kissing Technique Versus Jailed Wire Technique for the Coronary Bifurcation Lesions

Completed EARLY_PHASE1 Last updated 12 February 2018
What this trial tests

EARLY_PHASE1 trial testing Balloon-Stent Kissing technique in Coronary Artery Disease in 89 participants. Completed in 1 July 2017.

Timeline
1 January 2013
Primary endpoint
1 May 2016
1 July 2017

Quick facts

Lead sponsorDalian University
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingdouble
Primary purposetreatment
Enrollment89
Start date1 January 2013
Primary completion1 May 2016
Estimated completion1 July 2017
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Dalian University

Who can join

Adults 18 to 85, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the immediate and long-term clinical outcomes between Balloon-Stent Kissing Technique (BSKT) and Jailed Wire Technique (JWT) for the interventional treatment of coronary bifurcation lesions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Balloon-stent kissing technique versus jailed wire technique for interventional treatment of coronary bifurcation lesions: Comparison of short- and long-term clinical outcomes.
    Jin Z, Song L, Zheng Z, Zhang S, et al · · 2019 · cited 8× · PMID 31096478 · DOI 10.1097/md.0000000000015633

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Dalian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03429634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing